We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Presents Range of IVD Total Solutions for Laboratories of All Sizes

By LabMedica International staff writers
Posted on 04 Feb 2025

Mindray (Shenzhen, China) is exhibiting its comprehensive range of IVD total solutions designed for laboratories of all sizes. More...

Visitors to the Mindray booth can discover its exciting new innovations, including the CAL 9000 All-in-One Hematology Solution, the M980 Chemistry and Immunoassay Integrated Solution, and the FA-N60 Automated Blood Culture System, all aimed at enhancing laboratory efficiency.

The CAL 9000 is Mindray’s latest generation of advanced hematology cellular analysis line. It delivers CBC, ESR, and HbA1c results from a single EDTA tube using the "All-in-One" solution. Additionally, it features fully automated sample processing, and accurate disease-specific alarms which enable intelligent re-examination and digital morphology analysis. This high-performance line enhances diagnostic accuracy, reduces manual workload, and accelerates clinical decision-making for laboratories. The M980 is a powerful and efficient chemistry and immunoassay integrated solution with a compact footprint of just 2.6 m². Featuring innovative technologies such as the PDR platform, auto de-capping, ultrasonic probe washing, and FS sampling, it efficiently delivers reliable reports for patient care.

The FA-N60 is a next-generation scalable blood culture system that features real-time blood volume monitoring, an intelligent satellite information transmission system, and newly designed culture bottles. It enables rapid diagnosis of bloodstream infections with an optimized workflow. The fully automatic AF-300 ID/AST system offers a range of combinations using Mindray combo ID/AST cards. It can identify over 500 bacterial species with high sensitivity and employs direct minimum inhibitory concentrations (MICs) to detect emerging resistant pathogens, following CLSI and EUCAST guidelines. This ensures timely and accurate results for clinical microbiology testing. The BriCyte MX Flow Cytometer is optimized for configuration and performance, featuring an optical system with up to 3 lasers and 14 colors. It boasts significant improvements in key performance metrics, including multi-mode fluorescence compensation, expanded automatic algorithms, and innovative automated review, making flow cytometry analyses more standardized and efficient.

 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.